Hospital clinic de jobs in BarcelonaCreate job alerts

Surgical Device PartnerIr para o conteúdo principal#Surgical Device Partner page is loaded## Surgical Device PartnerCandidatar-selocations: Spaintime type: Tempo integralposted on: Publicado hojejob requisition id: Na Roche, você pode-se apresentar como você mesmo, abraçado pelas qualidades únicas que traz. Nossa cultura incentiva a expressão pessoal, o diálogo aberto e as conexões genuínas, onde você é valorizado e respeitado por quem você é, e permitindo que você prospere tanto pessoal como profissionalmente. É assim que pretendemos prevenir, deter e curar doenças e garantir que todos tenham acesso aos cuidados de saúde hoje e nas gerações futuras. Junte-se à Roche, onde cada voz é importante.### A posiçãoThis field-based role spans Spain, serving as the primary point of contact for technical information regarding the Portable Delivery System (PDS) in ophthalmic surgery. This includes operating rooms and ophthalmology clinics. As a crucial member of a high-performing technical team, the SDP is responsible for comprehensive training, certification, and technical product support for investigators and clinical staff. The aim is to ensure optimal patient outcomes. By collaborating with study sites and the global cross-functional team, the SDP contributes valuable technical insights to ophthalmic surgery device development programs.Your Key Responsibilities Act as the main channel for ophthalmic surgical technical information to and from the clinical environment (operating room, ophthalmology clinic), both within and outside clinical trials. Independently manage the preparation and execution of necessary training for all surgical procedures involving ophthalmic medical devices/the Port Delivery Platform for surgeons, ophthalmologists, and other ophthalmic HCPs. Provide ongoing remote and on-site support and training to surgical staff to ensure the proper use of the platform. Attend ophthalmic medical product/PD-P surgical procedures (implantation, revision, explantation, refilling-exchange) in the operating room (as per local regulations and strategy) and in the clinic to instruct and support surgeons and clinical staff during live cases. Deliver regulatory, safety, and risk minimization activities at the affiliate level, if required. Develop and maintain strategic relationships with surgeons, therapeutic area experts, and other key healthcare professionals. Collaborate with the Medical team to provide strategic scientific review of surgical materials and communications. Collect and share insights from the field.* Collaborate within a cross-functional team, including other SDPs and iSquad members, both locally and globally.Who You Are Bachelor's Degree in Scientific areas, such as Pharmacy, Biology, etc., or having another Bachelor's Degree and demonstrated Medical Education. Surgical and operating room experience. Strongly preferred and recommended: Ophthalmic operating room experience. Strongly preferred: Experience with Class III Medical Devices. Both in English and Spanish fluent level. Preferible to be located in Barcelona. Demonstrated excellent training and teaching abilities, characterized by strong self-confidence, efficiency, and clarity when interacting with diverse trainee audiences. Willingness to travel nationally approximately 70% of the time (around 3-4 days per week) and internationally (Europe) 1-3 times per year. Proficiency in GCP, Adverse Event Reporting, and ICH guidelines. Excellent communication, interviewing, presentation, and moderation skills, including clear and precise written and oral communication and a high level of professionalism in dealing with customers, doctors, nurses, and other medical staff. Ability to build strong and trusting relationships with health care providers Resilience, self-organization, independence, and a sense of responsibility for patient well-being. Attention to detail, strong organizational and time management skills. Highly motivated and flexible team player with a focus on the success of colleagues. Ability to adapt positively to change and demonstrate entrepreneurial and solution-oriented thinking. Maintain all required certifications and hospital vendor credentials relevant to the program.### Quem nós somosUm futuro mais saudável nos leva a inovar. Juntos, mais de 100 mil funcionários em todo o mundo se dedicam ao avanço da ciência, garantindo que todos tenham acesso à saúde hoje e nas próximas gerações. Nossos esforços resultam em mais de 26 milhões de pessoas tratadas com nossos medicamentos e mais de 30 bilhões de testes realizados usando nossos produtos de diagnóstico. Nós nos capacitamos para explorar novas possibilidades, promover a criatividade e manter as nossas ambições altas, para fornecer soluções de saúde que mudem a vida e causem um impacto global.Vamos construir juntos um futuro mais saudável.A Roche é um empregador que pratica políticas de igualdade de oportunidades.### About UsAcreditamos ser necessário oferecer soluções médicas agora – mesmo quando desenvolvemos inovações para o futuro. Nosso compromisso é transformar a vida dos pacientes. Temos coragem para decidir e agir. Acreditamos também que bons negócios significam um mundo melhor. É para isso que trabalhamos diariamente. Temos compromissos com o rigor científico, com a ética e com o acesso a inovações médicas para todos. Fazemos isso hoje para construir um amanhã melhor. Temos orgulho de quem somos, do que fazemos e de como fazemos. Somos muitos, trabalhando como um em todo o mundo. Somos Roche. br#J-18808-Ljbffr

ph3Background /h3 pEndometrial cancer (EC) is the fourth most common cancer in women, and its incidence is increasing. Despite the importance of early diagnosis for patient survival, there is no accurate and non?invasive strategy for early triage or screening of EC. Diagnosis relies on imaging and invasive biopsies, affecting more than 35 M women presenting symptoms – 86% postmenopausal and 14% premenopausal – and patients with hereditary risk – Lynch Syndrome – who have annual surveillance. Only 10% of those will have EC. /p h3Objective /h3 pThis project builds on our previous projects, and aims to advance the development of a non?invasive triage test based on protein biomarkers in cervical fluids for the accurate detection of atypical endometrial hyperplasia (AEH) and EC across high?risk populations. We will advance the development, preanalytical and analytical validation of the test using the recently developed key reagents, and assess its performance in symptomatic pre? and postmenopausal women prior and after imaging techniques, and Lynch Syndrome carriers. In parallel, we will investigate the proteomic landscape of EC progression using a transgenic mouse model, and cervical fluids from AEH patients, to elucidate tumour progression mechanisms and AEH biomarkers, with the ultimate goal to advance our triage test for EC prevention. This project is expected to transform EC diagnosis, improving patient care, quality of life, EC survival, and healthcare efficiency. /p h3Our Group /h3 pThe Group of Biomedical Research in Gynaecology (Gine Lab), integrated into the Vall d'Hebron Research Institute (VHIR), is a consolidated, multidisciplinary core consisting of 37 professionals who operate under a "two?way translational research" philosophy: from the patient to the laboratory and back to the clinic. The group is co?directed by Dr. Antonio Gil?Moreno, who leads the clinical strategy, and Dr. Eva Colás, who is responsible for translational research and innovation. Their activity is centred on resolving clinical needs in women's health through two main pillars: early non?invasive diagnosis and precision oncology. The research is structured into three primary vertical work lines: Endometrial Cancer: This research line is a pioneer in molecular diagnosis using gynaecological fluids (such as cervical fluid), employing proteomics to develop non?invasive triage tests aimed at avoiding unnecessary biopsies. Ovarian Cancer: This research line focuses on precision oncology and therapy optimisation. To this end, they utilise the Gyne PDX platform, a biobank featuring over 174 patient?derived xenograft (PDX) models and organoids, which is used for preclinical "clinical trials" of targeted therapies. Endometriosis: This research line integrates molecular classification and tissue proteomic characterisation with the development of a non?invasive diagnostic test based on protein biomarkers in cervical fluids, while simultaneously investigating angiogenic biomarkers to improve recurrence risk prediction. /p h3Innovation and Clinical Translation /h3 pGine Lab stands at the forefront of clinical innovation through a robust portfolio of active patents and the creation of its own femtech spin?off, Mi MARK Diagnostics S. L. (founded in ). This spin?off has secured approximately €8 M in funding, including a prestigious €2.5 M EIC Accelerator grant, to bring non?invasive in vitro diagnostic (IVD) tests to the global healthcare market. /p h3International Leadership and Strategic Collaborations /h3 pThe group holds a prominent position in the international scientific community: Consortia Coordination: Gine Lab coordinates the European Cyto MARK consortium (ERA Per Med), integrating proteomic markers and clinical data across five countries. Accreditations: The clinical headquarters at VHH maintains ESGO Accreditation as a Centre of Excellence for the surgical management of advanced ovarian cancer. Strategic Alliances: The group maintains high?level collaborations with institutions such as the Broad Institute of MIT and Harvard, the Luxembourg Institute of Health, and numerous European and US universities. Scientific Governance: Members hold leadership roles in the European Network for Individualised Treatment of Endometrial Cancer (ENITEC), the European Society of Gynaecological Oncology (ESGO), and the national Spain?GOG network. /p h3Social Impact and Talent Development /h3 pBeyond technical excellence, the group drives social change through the ENDO?HIT program, a pioneer citizen?science initiative that raises endometriosis awareness in schools and empowers women regarding their reproductive health. Furthermore, Gine Lab is a proven engine for academic development, having supervised 6 Ph D theses with honours since and maintaining a robust internal training program that attracts international talent from across Europe. /p h3Main responsibilities and duties /h3 ul liParticipate in translational research projects to improve endometrial cancer and endometriosis diagnosis through biomarker llaborate with other projects of the group, by promoting fruitful discussions or by helping in experimental work. /li liParticipate in general activities of the group. /li liSupport the principal researcher in managerial activities. /li /ul h3Education and qualifications – Required /h3 pApplicants must hold a Ph D degree or have successfully defended their thesis before the call deadline (09/09/2026). /p h3Mobility, Language and Publication Requirements /h3 pApplicants must comply with the mobility rule, meaning they must not have resided or carried out their main activity (work/studies) in the host country for more than 12 months during the 36 months prior to the call deadline. Fluency in English. First author in publications. Passionate, proactive, willing to learn and committed. /p h3Experience and knowledge – Required /h3 pApplicants must have a maximum of 8 years of postdoctoral research experience by the call deadline. This means candidates are generally eligible if they obtained their Ph D on or after 10/09/2018 (possible extensions may apply, e.G. parental leave or long?term illness). /p h3Experience and knowledge – Desirable /h3 ul liPrevious experience in a translational research group. /li liExperience in mass spectrometry and immunoassay, including experimental work and data analysis. /li liPrevious experience with handling of complex human samples. /li liPrevious postdoc experience. /li liEfficient in manuscript drafting. /li /ul h3What can we offer /h3 pIncorporation into the Vall d'Hebron Research Institute (VHIR), a public sector institution that promotes and develops biomedical research, innovation and teaching at Vall d'Hebron University Hospital (HUVH), the largest hospital in Barcelona and the largest within the Catalan Institute of Health (ICS). /p pA dynamic scientific environment of excellence, where cutting?edge biomedical projects are continuously ntinuous learning and career development pathways. /p pHealthy offering – "Feel Good, Feel VHIR": VHIR's wellbeing programme offers a variety of activities to help staff thrive—physically, mentally, and socially. /p pThrough four pillars—Feel Well, Feel Connected, Feel Empowered, Feel Welcomed—it fosters health, growth, and community. /p pInternational mobility support (Welcome Services): we aim to make your arrival in Barcelona smooth and pleasant by providing city information, guidance on required procedures, access to the International Welcome Desk, family support and assistance with finding accommodation. /p h3Deadline to apply /h3 p /p h3Equality and diversity statement /h3 pVHIR embraces Equality and Diversity. /p pAs reflected in our values we work toward ensuring inclusion and equal opportunity in recruitment, hiring, training and management for all staff within the organisation, regardless of gender, civil status, family status, sexual orientation, gender identity and expression, religion, age, functional diversity or ethnicity. /p h3Personal data protection /h3 pData Controller: Fundació Hospital Universitari Vall d'Hebron Institut de Recerca -VHIR-. /p pPurpose: Personnel selection. /p pLegal Basis: Your consent. /p pData retention period: One year. /p pIf you are selected, as long as the employment relationship is in force and legal responsibilities may arise. /p pData sharing: Does not occur, except for communications necessary to fulfil the purpose and those required by law to public and private bodies. /p pRights: You can access, rectify, delete, object to, and limit the processing of data, as well as request data portability where applicable, by contacting /p pDPO: . /p pMore information can be found here. /p pData Protection Authority: APDCAT. /p /p #J-18808-Ljbffr

ph3Development of an in vitro diagnostic triage test for patients at risk of endometrial hyperplasia and endometrial cancer based on protein biomarkers in cervical fluids /h3 pVHIR is seeking an outstanding and highly motivated postdoctoral researcher to apply for a Marie Sklodowska‑Curie Postdoctoral Fellowship and join the Biomedical Gynaecology Research Group. /p h3Marie Skłodowska‑Curie Actions – Postdoctoral Fellowships (MSCA‑PF) /h3 pThe Marie Skłodowska‑Curie Postdoctoral Fellowships (MSCA‑PF) are part of the Horizon Europe programme and support postdoctoral researchers in developing an original research and innovation project through international mobility. /p pThe programme aims to strengthen researchers’ careers through excellent science, international collaboration and interdisciplinary experience, while fostering integration in both academic and non‑academic environments. The MSCA‑PF call is highly competitive and represents an excellent opportunity to attract international talent and support researchers in consolidating their scientific careers through an ambitious mobility‑based fellowship. /p pThe 2026 call closes on 09/09/2026 (17:00 Brussels time). For candidates applying to a European Postdoctoral Fellowship, the fellowship duration is from 12 to 24 months. /p pFull eligibility details: MSCA Postdoctoral Fellowships 2026 /p h3Background /h3 pEndometrial cancer (EC) is the fourth most common cancer in women, and its incidence is increasing. Despite the importance of early diagnosis for patient survival, there is no accurate and non‑invasive strategy for early triage or screening of EC. Diagnosis relies on imaging and invasive biopsies, affecting more than 35M women presenting symptoms – 86% postmenopausal and 14% premenopausal – and patients with hereditary risk – Lynch Syndrome – who have annual surveillance. Only 10% of those will have EC. /p h3Objective /h3 pThis project builds on our previous projects, and aims to advance the development of a non‑invasive triage test based on protein biomarkers in cervical fluids for the accurate detection of atypical endometrial hyperplasia (AEH) and EC across high‑risk populations. We will advance the development, preanalytical and analytical validation of the test using the recently developed key reagents, and assess its performance in symptomatic pre‑ and postmenopausal women prior and after imaging techniques, and Lynch Syndrome carriers. In parallel, we will investigate the proteomic landscape of EC progression using a transgenic mouse model, and cervical fluids from AEH patients, to elucidate tumour progression mechanisms and AEH biomarkers, with the ultimate goal to advance our triage test for EC prevention. This project is expected to transform EC diagnosis, improving patient care, quality of life, EC survival, and healthcare efficiency. /p h3Our Group /h3 pThe Group of Biomedical Research in Gynaecology (GineLab), integrated into the Vall d’Hebron Research Institute (VHIR), is a consolidated, multidisciplinary core consisting of 37 professionals who operate under a "two‑way translational research" philosophy: from the patient to the laboratory and back to the clinic. The group is co‑directed by Dr. Antonio Gil‑Moreno, who leads the clinical strategy, and Dr. Eva Colás, who is responsible for translational research and innovation. /p pTheir activity is centred on resolving clinical needs in women’s health through two main pillars: early non‑invasive diagnosis and precision oncology. The research is structured into three primary vertical work lines: /p ul liEndometrial Cancer: This research line is a pioneer in molecular diagnosis using gynaecological fluids (such as cervical fluid), employing proteomics to develop non‑invasive triage tests aimed at avoiding unnecessary biopsies. /li liOvarian Cancer: This research line focuses on precision oncology and therapy optimisation. To this end, they utilise the GynePDX platform, a biobank featuring over 174 patient‑derived xenograft (PDX) models and organoids, which is used for preclinical "clinical trials" of targeted therapies. /li liEndometriosis: This research line integrates molecular classification and tissue proteomic characterisation with the development of a non‑invasive diagnostic test based on protein biomarkers in cervical fluids, while simultaneously investigating angiogenic biomarkers to improve recurrence risk prediction. /li /ul h3Innovation and Clinical Translation /h3 pGineLab stands at the forefront of clinical innovation through a robust portfolio of active patents and the creation of its own femtech spin‑off, MiMARK Diagnostics S.L. (founded in 2021). This spin‑off has secured approximately €8M in funding, including a prestigious €2.5M EIC Accelerator grant, to bring non‑invasive in vitro diagnostic (IVD) tests to the global healthcare market. /p h3International Leadership and Strategic Collaborations /h3 pThe group holds a prominent position in the international scientific community: /p ul liConsortia Coordination: GineLab coordinates the European CytoMARK consortium (ERA PerMed), integrating proteomic markers and clinical data across five countries. /li liAccreditations: The clinical headquarters at VHH maintains ESGO Accreditation as a Centre of Excellence for the surgical management of advanced ovarian cancer. /li liStrategic Alliances: The group maintains high‑level collaborations with institutions such as the Broad Institute of MIT and Harvard, the Luxembourg Institute of Health, and numerous European and US universities. /li liScientific Governance: Members hold leadership roles in the European Network for Individualised Treatment of Endometrial Cancer (ENITEC), the European Society of Gynaecological Oncology (ESGO), and the national Spain‑GOG network. /li /ul h3Social Impact and Talent Development /h3 pBeyond technical excellence, the group drives social change through the ENDO‑HIT program, a pioneer citizen‑science initiative that raises endometriosis awareness in schools and empowers women regarding their reproductive health. Furthermore, GineLab is a proven engine for academic development, having supervised 6 PhD theses with honours since 2022 and maintaining a robust internal training program that attracts international talent from across Europe. /p h3Main responsibilities and duties /h3 ul liParticipate in translational research projects to improve endometrial cancer and endometriosis diagnosis through biomarker research. /li liCollaborate with other projects of the group, by promoting fruitful discussions or by helping in experimental work. /li liParticipate in general activities of the group. /li liSupport the principal researcher in managerial activities. /li /ul h3Education and qualifications – Required /h3 ul liApplicants must hold a PhD degree or have successfully defended their thesis before the call deadline (09/09/2026). /li liApplicants must comply with the mobility rule, meaning they must not have resided or carried out their main activity (work/studies) in the host country for more than 12 months during the 36 months prior to the call deadline. /li liFluency in English. /li liFirst author in publications. /li liPassionate, proactive, willing to learn and committed. /li /ul h3Experience and knowledge – Required /h3 ul liApplicants must have a maximum of 8 years of postdoctoral research experience by the call deadline. This means candidates are generally eligible if they obtained their PhD on or after 10/09/2018 (possible extensions may apply, e.g. parental leave or long‑term illness). /li liPrevious experience in a translational research group. /li liExperience in mass spectrometry and immunoassay, including experimental work and data analysis. /li /ul h3Experience and knowledge – Desirable /h3 ul liPrevious experience with handling of complex human samples. /li liPrevious postdoc experience. /li liEfficient in manuscript drafting. /li /ul h3What can we offer /h3 ul liIncorporation into the Vall d’Hebron Research Institute (VHIR), a public sector institution that promotes and develops biomedical research, innovation and teaching at Vall d’Hebron University Hospital (HUVH), the largest hospital in Barcelona and the largest within the Catalan Institute of Health (ICS). /li liA dynamic scientific environment of excellence, where cutting‑edge biomedical projects are continuously developed. /li liContinuous learning and career development pathways. /li liHealthy offering – "Feel Good, Feel VHIR": VHIR’s wellbeing programme offers a variety of activities to help staff thrive—physically, mentally, and socially. Through four pillars—Feel Well, Feel Connected, Feel Empowered, Feel Welcomed—it fosters health, growth, and community. /li liInternational mobility support (Welcome Services): we aim to make your arrival in Barcelona smooth and pleasant by providing city information, guidance on required procedures, access to the International Welcome Desk, family support and assistance with finding accommodation. /li /ul h3Deadline to apply /h3 h3Equality and diversity statement /h3 pVHIR embraces Equality and Diversity. As reflected in our values we work toward ensuring inclusion and equal opportunity in recruitment, hiring, training and management for all staff within the organisation, regardless of gender, civil status, family status, sexual orientation, gender identity and expression, religion, age, functional diversity or ethnicity. /p h3Personal data protection /h3 pData Controller: Fundació Hospital Universitari Vall d’Hebron Institut de Recerca -VHIR-. Purpose: Personnel selection. Legal Basis: Your consent. Data retention period: One year. If you are selected, as long as the employment relationship is in force and legal responsibilities may arise. Data sharing: Does not occur, except for communications necessary to fulfill the purpose and those required by law to public and private bodies. Rights: You can access, rectify, delete, object to, and limit the processing of data, as well as request data portability where applicable, by contacting DPO: More information can be found here. Data Protection Authority: APDCAT. /p /p #J-18808-Ljbffr

Overview ¿Tiene su CV preparado? Si es así y confía en que este es el puesto ideal para usted, asegúrese de enviar su solicitud lo antes posible. Our client is a high-end hospital specializing in advanced regenerative medicine, located in Barcelona. We are looking for a Medical & Wellness Tourism VIP Agent to lead the development of international partnerships between the clinic and medical travel agencies, private physicians, or hospitals. The ideal candidate has deep knowledge and contacts within a patient-emitting region such as the USA, LATAM, Middle East, Asia, or Africa. Responsibilities • Establish and grow strong relationships with international medical tourism agencies, hospitals, and healthcare providers., • Identify and channel potential international patients to the clinic in Barcelona., • Coordinate patient referrals starting September 2025, ensuring smooth communication between international partners and the clinic., • Represent the clinic in meetings and events with key players in the medical tourism sector., • Collaborate closely with the medical and commercial teams to ensure a VIP experience for patients. What We Offer • Flexible collaboration: part-time or full-time., • Performance-based compensation., • Full professional support from a cutting-edge and visionary clinic., • The opportunity to work in a premium healthcare project with international reach. Qualifications • Previous experience working in a medical tourism agency or in an international patient reception department of a hospital., • Commercial experience and strong interpersonal skills., • Existing healthcare-related contacts (private physicians, hospitals, or high-net-worth patients)., • Familiarity with at least one international patient-emitting region., • Motivation, proactivity, and a results-driven mindset. xcskxlj, • Open and collaborative attitude, with the ability to work across cultures and time zones. #J-18808-Ljbffr

ppVeterinario Generalista + Estancias Especialidades - €30.500 Al Año Veterios Barcelona, Kingdom Of Spain, ES /ppDescripción del trabajo Buscamos un nuevo miembro como Veterinario Generalista en el Hospital Veterinario de Referencia Veterios en Madrid, donde tendrás la oportunidad de continuar formándote mientras trabajas junto a especialista en un Hospital de Referencia con los medios más punteros.Si los siguientes requisitos del puesto y la experiencia coinciden con sus habilidades, por favor, asegúrese de enviar su solicitud sin demora.El Hospital Veterinario de Referencia Veterios se encuentra en la Calle Arrastaria, 23, 28022 Madrid (junto al Centro Comercial Plenilunio) y dispone de 1.750 m² para el cuidado de las mascotas. En Veterios trabaja un equipo de más de 60 personas dirigido por especialistas europeos (Diplomados Europeos EBVS) y americanos (Diplomado americano AVDC). Es un hospital Cat Friendly Clinic acreditado con el Nivel Oro y cuenta con consultas, salas de espera y hospitalizaciones independientes para perros y gatos, sala de cuidados intensivos, sala de aislamiento para pacientes infecciosos, 3 quirófanos, sala de rehabilitación, aula de formación y mucho más. Además, dispone de los últimos avances en el diagnóstico y prevención de patologías:Resonancia Magnética.TAC.Laboratorio propio.Equipo de ecografía de última generación.Rayos X digitales.Requisitos:Grado o Licenciatura en Veterinaria.Experiencia en Clínica Veterinaria de pequeños animales o en Hospitales Veterinarios.Experiencia en el Servicio de Urgencias y Hospitalización.Condiciones:Contrato indefinido.Salario bruto anual de 30.500 € brutos/anualesTurnos rotatorios de mañana, tarde, noches y fines de semana a distribuir entre 8 compañerosSe trabajan 7 días de turno de noches cada 8 semanasLa rotación proporciona 5 fines de semana libres cada 8 semanasDentro de la rotación de 8 semanas, se incluyen semanas de especialidad en turno de mañana (mínimo de 8-9 semanas anuales aseguradas por contrato)Se proporciona formación continua a cargo de los distintos departamentos del hospital en seminarios clínicosIncorporación inmediata¿Por qué unirte a UNAVETS?Beneficios sociales: seguro médico pagado por la empresa (Asisa).Plan de Retribución Flexible: tickets restaurante, tarjeta transporte, guardería y seguro de salud para familiares.Formación continua veterinaria: programa de formaciones online y sesiones prácticas presenciales a través de la plataforma OneAcademy UNAVETS. xhfqzwm En UNAVETS nos sentimos profundamente agradecidos por la pasión y la entrega constante de cada miembro del equipo, si tú también quieres marcar una diferencia tan significativa en el mundo de la veterinaria ¡Queremos conocerte! /p /p #J-18808-Ljbffr